StockData
Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp (ADPT) stock

ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30
$28.46−0.03 (-0.11%)

Close on Nov 18, 2026Market cap $4.54BP/E –Yield –

Adaptive Biotechnologies market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Adaptive Biotechnologies's market cap was $4.76B on Nov 11, 2026, against $3.00B a year earlier. Over the last 5 years it ranged from $380.12M to $4.76B, with a median of $1.22B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.76B+92.2%
2025Dec 31, 2025$2.48B+180.1%
2024Dec 31, 2024$884.63M+24.7%
2023Dec 29, 2023$709.39M-35.1%
2022Dec 30, 2022$1.09B-72.4%
2021Dec 31, 2021$3.96B-50.9%
2020Dec 31, 2020$8.06B+116.8%
2019Dec 31, 2019$3.72B–

More Adaptive Biotechnologies figures

See a number that looks wrong?